Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer

This study has been completed.
Sponsor:
Information provided by:
Agenus, Inc.
ClinicalTrials.gov Identifier:
NCT00098085
First received: December 3, 2004
Last updated: March 6, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)